A phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study

Project Details

Short titleA phase IIa efficacy and safety trial with intravenous S95011 in primary Sjögren's Syndrome patients. An international, multicentre, randomized, double-blind, placebo-controlled study
StatusFinished
Effective start/end date1/03/21 → 19/05/23

Funding

  • Servier